2024 Q4 Form 10-Q Financial Statement

#000141057824002074 Filed on December 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $286.6K
YoY Change -30.7%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $286.6K
YoY Change -30.7%
Operating Profit -$375.0K
YoY Change 51.85%
Interest Expense $17.77K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$375.0K -$268.8K
YoY Change 53.93% -150.07%
Income Tax $7.990K
% Of Pretax Income
Net Earnings -$375.0K -$276.8K
YoY Change 47.85% -173.87%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.07
COMMON SHARES
Basic Shares Outstanding 3.425M 3.525M 3.556M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents $45.15K $8.651K
Short-Term Investments
Other Short-Term Assets $17.99K
YoY Change -93.29%
Inventory
Prepaid Expenses
Receivables
Other Receivables $63.32K $99.96K
Total Short-Term Assets $313.7K $118.0K
YoY Change -22.78% -89.06%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.294M
YoY Change -97.19%
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $2.600M $3.294M
YoY Change -20.07% -97.19%
TOTAL ASSETS
Total Short-Term Assets $313.7K $118.0K
Total Long-Term Assets $2.600M $3.294M
Total Assets $2.914M $3.412M
YoY Change -20.38% -97.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.099M
YoY Change 32.52%
Accrued Expenses $21.25K
YoY Change -86.98%
Deferred Revenue
YoY Change
Short-Term Debt $204.2K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.306M
YoY Change 165.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.306M
Total Long-Term Liabilities $0.00
Total Liabilities $3.978M $3.306M
YoY Change 21.39% 165.87%
SHAREHOLDERS EQUITY
Retained Earnings -$3.862M -$3.203M
YoY Change 33.48% 71.97%
Common Stock $324.00 $324.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.742M -$3.202M
YoY Change
Total Liabilities & Shareholders Equity $2.914M $3.412M
YoY Change -20.38% -97.12%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$375.0K -$276.8K
YoY Change 47.85% -173.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$293.9K
YoY Change 53.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -293.9K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -293.9K
YoY Change -188.09%
FREE CASH FLOW
Cash From Operating Activities -$293.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 wavs Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
375004
wavs Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
1211464
wavs Franchise Tax
FranchiseTax
-3247
CY2024Q3 us-gaap Financing Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Financing Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://ir.system1.com/20240930#SponsorMember
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://ir.system1.com/20240930#SponsorMember
CY2024Q3 us-gaap Notes Payable Current Related Party Type Extensible Enumeration
NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Notes Payable Current Related Party Type Extensible Enumeration
NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://ir.system1.com/20240930#SponsorMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://ir.system1.com/20240930#SponsorMember
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001868419
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
wavs Due To Trust Account
DueToTrustAccount
63319
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41214
dei Entity Registrant Name
EntityRegistrantName
Western Acquisition Ventures Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3720717
dei Entity Address Address Line1
EntityAddressAddressLine1
42 Broadway, 12th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10004
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
740-0710
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3424879
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
45150
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
8651
CY2024Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
185000
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
63319
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
99961
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20250
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9338
CY2024Q3 us-gaap Assets Current
AssetsCurrent
313719
CY2023Q4 us-gaap Assets Current
AssetsCurrent
117950
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
2600462
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
3293966
CY2024Q3 us-gaap Assets
Assets
2914181
CY2023Q4 us-gaap Assets
Assets
3411916
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1852546
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1099166
CY2024Q3 wavs Due To Trust Account Current
DueToTrustAccountCurrent
63319
CY2023Q4 wavs Due To Trust Account Current
DueToTrustAccountCurrent
99961
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
576175
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
204222
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
230000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
76000
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
665116
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1149502
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1143296
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
12500
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
72824
CY2024Q3 wavs Franchise Tax Payable Current
FranchiseTaxPayableCurrent
-18000
CY2023Q4 wavs Franchise Tax Payable Current
FranchiseTaxPayableCurrent
-21247
CY2024Q3 us-gaap Liabilities
Liabilities
3978042
CY2023Q4 us-gaap Liabilities
Liabilities
3305832
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
324
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
324
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119521
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3862137
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3202604
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3742292
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3202280
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2914181
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3411916
CY2023Q3 wavs Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
247757
wavs Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
790882
CY2023Q3 wavs Franchise Tax
FranchiseTax
-800
wavs Franchise Tax
FranchiseTax
21250
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-375004
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-246957
us-gaap Operating Income Loss
OperatingIncomeLoss
-1208217
us-gaap Operating Income Loss
OperatingIncomeLoss
-812132
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
48576
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
331690
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-45239
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
665116
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-212503
wavs Non Redemption Agreement Related Expenses
NonRedemptionAgreementRelatedExpenses
127224
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-375004
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-243620
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-670325
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-692945
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10013
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64836
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-375004
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-253633
us-gaap Net Income Loss
NetIncomeLoss
-670325
us-gaap Net Income Loss
NetIncomeLoss
-757781
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3202280
CY2024Q1 wavs Excise Tax Liability Arising From Redemption Of Shares
ExciseTaxLiabilityArisingFromRedemptionOfShares
3274
CY2024Q1 wavs Reduction Of Carrying Value To Redemption Value Due To Tax
ReductionOfCarryingValueToRedemptionValueDueToTax
17000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
408380
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2780174
CY2024Q2 wavs Excise Tax Liability Arising From Redemption Of Shares
ExciseTaxLiabilityArisingFromRedemptionOfShares
2934
CY2024Q2 wavs Adjustments To Additional Paid In Capital Expense Related To Issuance Of Non Redemption Agreements
AdjustmentsToAdditionalPaidInCapitalExpenseRelatedToIssuanceOfNonRedemptionAgreements
127224
CY2024Q2 wavs Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemableStock
7745
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-703701
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-3367330
CY2024Q3 wavs Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemableStock
-42
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-375004
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3742292
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-256387
CY2023Q1 wavs Adjustments To Additional Paid In Capital Increase Decrease Through Forward Purchase Agreement
AdjustmentsToAdditionalPaidInCapitalIncreaseDecreaseThroughForwardPurchaseAgreement
-430021
CY2023Q1 wavs Adjustments To Additional Paid In Capital Increase Decrease Through Excise Tax Liability Arising From Redemption Of Shares
AdjustmentsToAdditionalPaidInCapitalIncreaseDecreaseThroughExciseTaxLiabilityArisingFromRedemptionOfShares
-1094366
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
170661
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-171611
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2123046
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
95533
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-332537
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2551116
CY2023Q3 wavs Excise Tax Liability Arising From Redemption Of Shares
ExciseTaxLiabilityArisingFromRedemptionOfShares
48930
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
39463
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-253633
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2893142
us-gaap Profit Loss
ProfitLoss
-670325
us-gaap Profit Loss
ProfitLoss
-757781
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
331690
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
665116
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-212503
wavs Non Redemption Agreement Related Expenses
NonRedemptionAgreementRelatedExpenses
127224
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10912
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-182370
wavs Increase Decrease In Accounts Payable Accrued Liabilities And Income Tax Payables
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxPayables
753380
wavs Increase Decrease In Accounts Payable Accrued Liabilities And Income Tax Payables
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxPayables
188105
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-60324
wavs Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-3247
wavs Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-142000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17684
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1694
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-511636
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-646799
wavs Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
-72866
wavs Payment For Deposit To Trust Account
PaymentForDepositToTrustAccount
60100
wavs Payments Made In Connection With Cycurion Promissory Note
PaymentsMadeInConnectionWithCycurionPromissoryNote
185000
wavs Proceeds From Cash Withdrawn From Trust Account
ProceedsFromCashWithdrawnFromTrustAccount
620636
wavs Proceeds From Cash Withdrawn From Trust Account
ProceedsFromCashWithdrawnFromTrustAccount
114329594
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
508502
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
114269494
wavs Proceeds From Loans Outstanding
ProceedsFromLoansOutstanding
354269
wavs Proceeds From Loans Outstanding
ProceedsFromLoansOutstanding
200000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
230000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
76000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
620636
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
114329594
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39633
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-114129594
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
36499
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
-506899
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8651
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
809481
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45150
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302582
wavs Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
430021
wavs Excise Tax Liability Arising From Redemption Of Class Shares
ExciseTaxLiabilityArisingFromRedemptionOfClassShares
6207
wavs Excise Tax Liability Arising From Redemption Of Class Shares
ExciseTaxLiabilityArisingFromRedemptionOfClassShares
1143296
wavs Accretion Of Common Stock Subject To Possible Redemption To Redemption Value
AccretionOfCommonStockSubjectToPossibleRedemptionToRedemptionValue
7787
wavs Accretion Of Common Stock Subject To Possible Redemption To Redemption Value
AccretionOfCommonStockSubjectToPossibleRedemptionToRedemptionValue
305657
wavs Temporary Equity Dilution Of Carrying Value To Redemption Value
TemporaryEquityDilutionOfCarryingValueToRedemptionValue
17000
wavs Payments Made In Connection With Cycurion Promissory Notes
PaymentsMadeInConnectionWithCycurionPromissoryNotes
110000
wavs Payments Made In Connection With Sponsor Promissory Note
PaymentsMadeInConnectionWithSponsorPromissoryNote
110000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
8651
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8651
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
45150
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
45150
wavs Numberofsharesofcommonstocktobeissuedasbusinesscombinationmarketingagreementfee
Numberofsharesofcommonstocktobeissuedasbusinesscombinationmarketingagreementfee
250000
CY2022Q1 wavs Proceeds From Sale Of Units
ProceedsFromSaleOfUnits
116150000
CY2022Q1 wavs Unit Price
UnitPrice
10.1
CY2024Q3 wavs Percentage Of Assets Held In Trust Entering Into Business Combination Agreement
PercentageOfAssetsHeldInTrustEnteringIntoBusinessCombinationAgreement
0.80
CY2024Q3 wavs Percentage Of Post Transaction Ownership Required To Complete Business Combination
PercentageOfPostTransactionOwnershipRequiredToCompleteBusinessCombination
0.50
CY2024Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.83
CY2024Q3 wavs Redemption Of Redeemable Common Stock Minimum Net Tangible Assets Requirement
RedemptionOfRedeemableCommonStockMinimumNetTangibleAssetsRequirement
5000001
wavs Percentage Of Shares Subject To Lockup Provision
PercentageOfSharesSubjectToLockupProvision
0.15
wavs Percentage Of Commitment Redemption
PercentageOfCommitmentRedemption
1
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
100
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
31143
CY2024Q1 wavs Stock Redemption Redemption Price Per Share
StockRedemptionRedemptionPricePerShare
10.51
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
327375
CY2024Q2 wavs Amount To Be Deposited In Trust Account For Extending Termination Date Of Investment Management Trust Agreement
AmountToBeDepositedInTrustAccountForExtendingTerminationDateOfInvestmentManagementTrustAgreement
100
CY2024Q2 wavs Proceeds From Capital Raise Deposited Into Operating Bank Account
ProceedsFromCapitalRaiseDepositedIntoOperatingBankAccount
254269
CY2024Q1 wavs Excess Amount Erroneously Withdrawn From Trust Account
ExcessAmountErroneouslyWithdrawnFromTrustAccount
108611
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
45150
wavs Amount Erroneously Withdrawn From Trust Account Intended To Be Deposited Back Into Trust Account
AmountErroneouslyWithdrawnFromTrustAccountIntendedToBeDepositedBackIntoTrustAccount
63319
wavs Excess Amount Erroneously Withdrawn From Trust Account Intended To Use For Tax Obligations Until Deposited
ExcessAmountErroneouslyWithdrawnFromTrustAccountIntendedToUseForTaxObligationsUntilDeposited
63319
CY2024Q3 wavs Amount To Be Deposited In Trust Account For Extending Termination Date Of Investment Management Trust Agreement
AmountToBeDepositedInTrustAccountForExtendingTerminationDateOfInvestmentManagementTrustAgreement
100
CY2024Q3 wavs Maximum Dissolution Expenses Payable
MaximumDissolutionExpensesPayable
100000
CY2024Q3 us-gaap Share Price
SharePrice
10.1
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
45150
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8651
CY2024Q3 wavs Working Capital Deficit
WorkingCapitalDeficit
3664323
CY2023 wavs Excess Amount Erroneously Withdrawn From Trust Account
ExcessAmountErroneouslyWithdrawnFromTrustAccount
108611
wavs Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
597824
wavs Due From Sponsor
DueFromSponsor
63319
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
45150
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The preparation of the unaudited consolidated condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated condensed financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>
CY2024Q3 us-gaap Cash
Cash
45150
CY2023Q4 us-gaap Cash
Cash
45150
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
45150
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8651
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
wavs Excess Amount Erroneously Withdrawn From Trust Account
ExcessAmountErroneouslyWithdrawnFromTrustAccount
108611
CY2024Q3 wavs Excess Amount Erroneously Withdrawn From Trust Account
ExcessAmountErroneouslyWithdrawnFromTrustAccount
108611
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Concentration of Credit Risk</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of </span><span style="font-family:'Times New Roman','Times','serif';">$250,000</span><span style="font-family:'Times New Roman','Times','serif';">. As of September 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11876000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11876000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11876000
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11876000
CY2022Q1 wavs Units Issued During Period Shares New Issues
UnitsIssuedDuringPeriodSharesNewIssues
11500000
CY2021Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
wavs Underwriting Option Period
UnderwritingOptionPeriod
P45D
CY2021Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
wavs Debt Instrument Amortization Percentage
DebtInstrumentAmortizationPercentage
0.045
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5175000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
430021
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
665116
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1149502
wavs Excise Tax Payable As Percentage Of Shares Redeemed
ExciseTaxPayableAsPercentageOfSharesRedeemed
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3251000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3251000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
wavs Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
18
wavs Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
20
wavs Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
30
CY2024Q3 wavs Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.2
wavs Percentage Of Gross Proceeds On Total Equity Proceeds
PercentageOfGrossProceedsOnTotalEquityProceeds
0.60
wavs Threshold Trading Days For Calculating Market Value
ThresholdTradingDaysForCalculatingMarketValue
20
CY2024Q3 wavs Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.2
wavs Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price2
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice2
1.15
CY2023Q4 wavs Forward Purchase Agreement Liability
ForwardPurchaseAgreementLiability
665116
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
430021
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
665116
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
665116
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-665116
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-002074-index-headers.html Edgar Link pending
0001410578-24-002074-index.html Edgar Link pending
0001410578-24-002074.txt Edgar Link pending
0001410578-24-002074-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wavs-20240930.xsd Edgar Link pending
wavs-20240930x10q.htm Edgar Link pending
wavs-20240930xex31d1.htm Edgar Link pending
wavs-20240930xex31d2.htm Edgar Link pending
wavs-20240930xex32d1.htm Edgar Link pending
wavs-20240930xex32d2.htm Edgar Link pending
wavs-20240930x10q_htm.xml Edgar Link completed
wavs-20240930_def.xml Edgar Link unprocessable
wavs-20240930_cal.xml Edgar Link unprocessable
wavs-20240930_lab.xml Edgar Link unprocessable
wavs-20240930_pre.xml Edgar Link unprocessable